Department of Pathology, PSG Institute of Medical Sciences and Research, Coimbatore, India.
Pathol Res Pract. 2022 Aug;236:153981. doi: 10.1016/j.prp.2022.153981. Epub 2022 Jun 17.
Due to Corona Virus disease -19, India saw a surge of mucormycosis cases, associated with high death rate. India, during the month of May to July 2021 saw a surge of mucormycosis from all states, with close to 50,000 cases just in a span of 3 months.
To examine the histopathological appearances of rhino-orbital/rhino-maxillary/sino-nasal mucormycosis in the backdrop of the ongoing COVID 19 pandemic.
The study involved analysis of 60 biopsy samples of suspected rhino-maxillary /rhino-orbital mucormycosis received from post-COVID-19 patients. A preliminary review of the slides showing hyphal forms of fungal organisms with un-doubtful tissue / mucosal invasion was included. All samples were examined under Hematoxylin and Eosin stains along with special fungal stains. Data thus obtained were analyzed statistically. Special stains for fungus namely Periodic Acidic Schiff (PAS) and Gomori Methenamine silver (GMS) were utilized to confirm and/or to differentiate the fungal organisms and to highlight the cell wall of the fungus.
The mean age of the patients with mucormycosis was 51.68 years and 72 (83.33%) of them were males. Acute type of inflammation was noted in 44 (73.33%), granulomatous inflammation in 14 (23.33%) of cases. Bony invasion and perineural invasion was observed in 5 (8.33%) and 55 (91.67%) cases, respectively. The dominant fungus were mucorales in 58 (96.67%), aspergillous, along with mucorales in 12 (20%) and combination of mucorales and candida identified in 8 (13.33%) cases.
Besides all the histological appearance of angioinvasion, bone, and soft tissue invasion, a notable aspect was the shift in inflammatory pattern, which was more granulomatous in nature, with a decrease in fungal load correlating with the drop of COVID second wave. This proves that as immunity develops, the host's response to secondary opportunistic infections changes.
由于 2019 年冠状病毒病,印度的毛霉菌病病例激增,死亡率很高。印度在 2021 年 5 月至 7 月期间,所有邦的毛霉菌病病例激增,仅在 3 个月内就有近 5 万例。
在持续的 COVID-19 大流行背景下,检查鼻-眶-鼻上颌/鼻-上颌-鼻窦毛霉菌病的组织病理学表现。
本研究分析了 60 例来自 COVID-19 后患者的疑似鼻上颌/鼻眶毛霉菌病活检样本。初步回顾了显示真菌菌丝形态且具有明确组织/黏膜侵犯的幻灯片。所有样本均用苏木精和伊红染色以及特殊真菌染色进行检查。统计分析所获得的数据。特殊真菌染色剂,即过碘酸希夫(PAS)和高碘酸希夫-银染色(GMS),用于确认和/或区分真菌,并突出真菌细胞壁。
毛霉菌病患者的平均年龄为 51.68 岁,其中 72 例(83.33%)为男性。44 例(73.33%)为急性炎症,14 例(23.33%)为肉芽肿性炎症。5 例(8.33%)观察到骨侵犯,55 例(91.67%)观察到神经周围侵犯。主要真菌为毛霉属,占 58 例(96.67%),曲霉菌和毛霉属共 12 例(20%),毛霉属和念珠菌属共 8 例(13.33%)。
除了所有血管侵犯、骨和软组织侵犯的组织学表现外,一个显著的方面是炎症模式的转变,其性质更具肉芽肿性,真菌负荷减少与 COVID 第二波下降相关。这证明随着免疫力的发展,宿主对继发性机会性感染的反应发生变化。